Implications of and perspectives on HIV surveillance using a serological method to measure recent HIV infections in newly diagnosed individuals: Results from a pilot study in Berlin, Germany, in 2005-2007

HIV Medicine

Volumn 10, Issue 4, 2009, Pages 209-218

  Bätzing Feigenbaum, Jörg ^a   Loschen, S ^a   Gohlke Micknis, S ^a   Hintsche, B ^b   Rausch, M ^c   Hillenbrand, H ^d   Cordes, C ^d   Poggensee, G ^a   Kucherer C ^a   Hamouda, O ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Private Practice Hintsche / Klausen   (Germany)

^c Practice Freiwald/Rausch   (Germany)

^d Practice Bieniek/Cordes   (Germany)

Author keywords

BED CEIA; HIV incidence; KAB survey; Recency of infection; Second generation HIV surveillance

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGE; ARTICLE; ATTITUDE TO ILLNESS; BLOOD SAMPLING; CLINICAL EXAMINATION; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PILOT STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; ATTITUDE TO HEALTH; EPIDEMIOLOGY; HIV INFECTIONS; HIV SEROPOSITIVITY; MALE HOMOSEXUALITY; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; BERLIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD; YOUNG ADULT;

EID: 62749204399     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00672.x     Document Type: Article

References (40)

1. Hamouda O. HIV/AIDS surveillance in Germany. J Acquir Immune Defic Syndr 2003; 32 (Suppl. II): S49-S54.
2. Robert Koch Institut. HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten (Stand vom 01.03.2007) [HIV infections and AIDS disease in Germany. Epidemiological update]. Halbjahresbericht II/2006 aus dem Robert Koch Institut. Epidemiologisches Bulletin, Berlin, 29 Mai 2007; Sonderausgabe A. 2007
3. Robert Koch Institut. HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten (Stand vom 01.09.2007) [HIV infections and AIDS diseases in Germany. Epidemiological update]. Halbjahresbericht I/2007 aus dem Robert Koch Institut. Epidemiologisches Bulletin, Berlin, 3 Oktober 2007; Sonderausgabe B. 2007
4. Hamouda O, Marcus U, Voß L, Kollan C. Verlauf der HIV-Epidemie in Deutschland [Epidemiology of HIV infections in Germany]. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2007; 50: 399-411.
5. Janssen RS, Satten GA, Stramer SL et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280: 42-48.
6. Suligoi B, Massi M, Galli C et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 2003; 32: 424-428.
7. Murphy G, Charlett A, Osner N, Gill ON, Parry JV. Reconciling HIV incidence results from two assays employed in the serological testing algorithm for recent HIV seroconversion (STARHS). J Virol Methods 2003; 13: 79-86.
8. Dobbs T, Kennedy MS, Pau CP, McDougal JS, Parekh BS. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004; 42: 2623-2628.
9. Barin F, Meyer L, Lancar R et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 2005; 43: 4441-4447.
10. Martro E, Suligoi B, Gonzalez V et al. Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol 2005; 43: 6197-6199.
11. Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res 2005; 121: 510-518.
12. McDougal JS, Parekh BS, Peterson ML et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006; 22: 945-952.
13. Parekh BS, Kennedy MS, Dobbs T et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18: 295-307.
14. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures - new insights into the South African epidemic. S Afr Med J 2007; 97: 194-199.
15. Sakarovitch C, Rouet F, Murphy G et al. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr 2007; 45: 115-121.
16. Fisher M, Pao D, Murphy G et al. Serological testing algorithm shows rising HIV incidence in a UK cohort of men having sex with men: 10 years application. AIDS 2007; 21: 2309-2314.
17. Hargrove JW, Humphrey JH, Mutasa K et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008; 22: 511-518.
18. Hall HI, Song R, HIV Incidence Surveillance Group et al. Estimation of HIV incidence in the United States. JAMA 2008; 300: 520-529.
19. Loschen S, Bätzing-Feigenbaum J, Poggensee G et al. Identification of recent HIV infection: Comparison of the HIV-1 specific IgG capture ELISA (BED-CEIA) with the avidity index method. J Clin Microbiol 2008; 46: 341-345.
20. Schwartz S, Kellogg T, McFarland W et al. Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: Application of the serological testing algorithm for recent HIV seroconversion. Am J Epidemiol 2001; 153: 925-934.
21. McFarland W, Busch MP, Kellogg TA et al. Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counselling and testing sites in San Francisco. J Acquir Immune Defic Syndr 1999; 22: 484-489.
22. Puchhammer-Stockl E, Schmied B, Rieger A et al. Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity. J Clin Microbiol 2005; 43: 497-498.
23. Semaille C, Barin F, Cazein F et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: Experience after 2 years in France. J Infect Dis 2007; 196: 377-383.
24. Bio Fernandes S, Martins HC, Trigo H, Leitao E, Coutinho R, Paixao MT. Estimativa da seroincidência do virus da immunodeficiência humana do tipo 1 num grupo de toxicodependentes: Uma nova abordagem [Human immunodeficiency virus type 1 seroincidence estimate among a group of drug users: A new approach]. Acta Med Port 2005; 18: 37-44.
25. Gebhardt M, Daneel S, Vernazza P et al. Intensivierte epidemiologische Surveillance von HIV-Erstdiagnosen in der Schweiz [Intensified epidemiological surveillance of HIV case detection in Switzerland]. Eur J Med Res 2007; 12 (Suppl. II): 1.
26. Centers for Disease Control and Prevention. HIV Incidence Surveillance: Estimating National and Local HIV Incidence Using a Population-Based Serological Method to Detect Recent HIV-1 Infection. Atlanta: CDC, Division of HIV/AIDS Prevention, HIV Incidence and Case Surveillance Branch, 2005.
27. Lot F, Semaille C, Cazerin F et al. Preliminary results from the new HIV surveillance system in France. Eur Surveill 2004; 9: 34-37.
28. Harms V. Biomathematik, Statistik und Dokumentation, p. 69. Kiel, Germany: Harms Verlag, 1992.
29. Robert Koch Institut. HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten (Stand vom 01.03.2006) [HIV infections and AIDS diseases in Germany. Epidemiological update]. Halbjahresbericht II/2005 aus dem Robert Koch Institut. Epidemiologisches Bulletin, Berlin, 28 April 2006, Sonderausgabe A. 2006.
30. Robert Koch Institut. HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Aktuelle epidemiologische Daten (Stand vom 01.09.2006) [HIV infections and AIDS diseases in Germany. Epidemiological update]. Halbjahresbericht I/2006 aus dem Robert Koch Institut. Epidemiologisches Bulletin, Berlin, 31 Oktober 2006, Sonderausgabe B. 2006.
31. Kremer H, Steffan E for the German Competence Network. HIV/AIDS Barriers and motivators to participation of women living with HIV in clinical trials and research studies. Eur J Med Res 2007; 12 (Suppl. II): 9.
32. Schenk L, Neuhauser H. Methodische Standards für eine migrantensensible Forschung in der Epidemiologie [Methodological standards in migrant-sensitive epidemiological research]. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2005; 48: 279-286.
33. Loschen S, Bätzing-Feigenbaum J, Gohlke-Micknis S et al. Differentiation of recent and chronic HIV-infections from filter dried-plasma-spots. Eur J Med Res 2007; 12 (Suppl. II): 118.
34. Rice BD, Bätzing-Feigenbaum J, Hosegood V et al. Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 2007; 7: 160.
35. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339: 33-39.
36. Pilcher CD, Chuan Tien H for the Quest Study and the Duke-UNC-Emory Acute HIV Consortium et al. Brief but efficient: Acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189: 1785-1791.
37. Waver MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-1409.
38. Brenner BG, Roger M, Quebec Primary HIV Infection Study Group et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195: 951-959.
39. Pinkerton ST. How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission? AIDS 2007; 21: 1625-1629.
40. Smith DE, Walker BD, Cooper DA, Rosenberg ES, Kaldor JM. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS 2004; 18: 709-718.